title: Oncostatin M induces growth arrest of skeletal muscle cells in G1 phase by regulating cyclin D1 protein level.
abstract: Oncostatin M (OSM), an IL-6 family cytokine, either inhibits or enhances the growth of cells depending on cell type. Here, we report that OSM inhibits proliferation of skeletal muscle cells by blocking cell cycle progression from G(1) to S phase. OSM treatment significantly reduced levels of cyclin D1 protein and phosphorylation of retinoblastoma protein (Rb) at Ser-795, a CDK4-specific phosphorylation site. The OSM-induced cyclin D1 reduction correlated with decreased amount of the cyclin D1/p27 Kip1 complex and increased amounts of the CDK2/p27 Kip1 complex, resulting in inhibition of CDK2 activity. Results obtained with lactacystin, a proteasome inhibitor, demonstrated that cyclin D1 reduction occurred through ubiquitin/proteasome proteolysis. In addition, activation of STAT3, but not STAT1, is likely to regulate OSM-induced cyclin D1 reduction. Dominant negative (DN)-STAT3 blocked OSM-induced cyclin D1 reduction, and constitutively active-STAT3 also induced cyclin D1 reduction. These results suggest that OSM arrests skeletal muscle cell growth at the G1/S checkpoint and that this response occurs by an ubiquitin/proteasome-dependent cyclin D1 protein reduction which is regulated by STAT3.
authors.affiliation: Division of Brain Disease, Center for Biomedical Sciences, National Institute of Health, Seoul 122-701, Republic of Korea.
authors.forename: Hyuck
authors.initials: H
authors.lastname: Kim
authors.forename: Chulman
authors.initials: C
authors.lastname: Jo
authors.forename: Bong Geom
authors.initials: BG
authors.lastname: Jang
authors.forename: Uhtaek
authors.initials: U
authors.lastname: Oh
authors.forename: Sangmee Ahn
authors.initials: SA
authors.lastname: Jo
mesh_terms: D000818:Animals; D002453:Cell Cycle / Q000187:drug effects / Q000502:physiology; D002460:Cell Line; D049109:Cell Proliferation; D056741:Cyclin D; D051357:Cyclin-Dependent Kinase 2 / Q000378:metabolism; D050760:Cyclin-Dependent Kinase Inhibitor p27 / Q000378:metabolism; D016213:Cyclins / Q000378:metabolism*; D016193:G1 Phase / Q000187:drug effects*; D051379:Mice; D018482:Muscle, Skeletal / Q000166:cytology*; D053683:Oncostatin M / Q000494:pharmacology* / Q000502:physiology*; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D050796:STAT3 Transcription Factor / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology; D025801:Ubiquitin / Q000378:metabolism
chemical_list: C493961:Cdkn1b protein, mouse; D056741:Cyclin D; D016213:Cyclins; D050796:STAT3 Transcription Factor; C494087:Stat3 protein, mouse; D025801:Ubiquitin; D053683:Oncostatin M; D050760:Cyclin-Dependent Kinase Inhibitor p27; C495893:Cdk2 protein, mouse; D051357:Cyclin-Dependent Kinase 2; D046988:Proteasome Endopeptidase Complex